Garry D. Tan

2.0k total citations
38 papers, 1.5k citations indexed

About

Garry D. Tan is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Epidemiology. According to data from OpenAlex, Garry D. Tan has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Physiology and 9 papers in Epidemiology. Recurrent topics in Garry D. Tan's work include Diet, Metabolism, and Disease (7 papers), Diet and metabolism studies (6 papers) and Adipose Tissue and Metabolism (6 papers). Garry D. Tan is often cited by papers focused on Diet, Metabolism, and Disease (7 papers), Diet and metabolism studies (6 papers) and Adipose Tissue and Metabolism (6 papers). Garry D. Tan collaborates with scholars based in United Kingdom, Italy and South Sudan. Garry D. Tan's co-authors include Fredrik Karpe, Saoirse E. O’Sullivan, Khalid Jadoon, E. Louise Thomas, Jimmy D. Bell, David B. Savage, Stephen O’Rahilly, Krishna Chatterjee, Rustam Rea and Alistair Lumb and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Garry D. Tan

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Garry D. Tan United Kingdom	18	559	440	405	379	323	38	1.5k
Yii‐Der Ida Chen United States	23	562 1.0×	576 1.3×	330 0.8×	547 1.4×	110 0.3×	54	1.8k
Yi‐Jen Hung Taiwan	26	330 0.6×	467 1.1×	305 0.8×	464 1.2×	179 0.6×	114	1.9k
Pierre‐Henri Ducluzeau France	26	502 0.9×	682 1.6×	433 1.1×	360 0.9×	94 0.3×	49	1.8k
Konstantinos Avgerinos United States	17	667 1.2×	502 1.1×	287 0.7×	183 0.5×	120 0.4×	25	1.9k
Satya Dash Canada	19	507 0.9×	450 1.0×	371 0.9×	764 2.0×	118 0.4×	58	1.8k
So Hun Kim South Korea	23	621 1.1×	417 0.9×	504 1.2×	483 1.3×	65 0.2×	78	1.9k
Catherine R. Mikus United States	20	1.3k 2.3×	376 0.9×	450 1.1×	616 1.6×	155 0.5×	31	2.3k
Amélio F. Godoy‐Matos Brazil	17	312 0.6×	284 0.6×	460 1.1×	426 1.1×	189 0.6×	45	1.4k
Paska A. Permana United States	26	1.1k 2.0×	862 2.0×	823 2.0×	567 1.5×	187 0.6×	52	2.6k
Hajime Yamakage Japan	22	443 0.8×	404 0.9×	231 0.6×	269 0.7×	103 0.3×	95	1.6k

Countries citing papers authored by Garry D. Tan

Since Specialization

Citations

This map shows the geographic impact of Garry D. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry D. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry D. Tan more than expected).

Fields of papers citing papers by Garry D. Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry D. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry D. Tan. The network helps show where Garry D. Tan may publish in the future.

Co-authorship network of co-authors of Garry D. Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Garry D. Tan. A scholar is included among the top collaborators of Garry D. Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry D. Tan. Garry D. Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buckley, Adam, et al.. (2025). Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study. Diabetologia. 68(9). 2069–2076. 3 indexed citations

Colosimo, Santo, Dimitrios A. Koutoukidis, Thomas Marjot, et al.. (2024). Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD. Diabetes Research and Clinical Practice. 217. 111820–111820. 5 indexed citations

Dyson, Pamela, et al.. (2024). Prolonged remission followed by low insulin requirements in a patient with type 1 diabetes on a very low-carbohydrate diet. Endocrinology Diabetes and Metabolism Case Reports. 2024(1). 2 indexed citations

Kozłowska, Olga, Helen Aveyard, Crispin Jenkinson, et al.. (2023). Developing and exploring the validity of a patient reported experience measure for adult inpatient diabetes care. Diabetic Medicine. 41(4). 1 indexed citations

Dyson, Pamela, et al.. (2023). Type 1 diabetes and low carbohydrate diets—Defining the degree of nutritional ketosis. Diabetic Medicine. 40(10). e15178–e15178. 8 indexed citations

Morris, Elizabeth, Michaela Noreik, Ly‐Mee Yu, et al.. (2023). Dietary Approaches to the Management of Type 2 Diabetes (DIAMOND) in Primary Care: A Protocol for a Cluster Randomised Trial. SSRN Electronic Journal. 1 indexed citations

Morris, Elizabeth, Michaela Noreik, Ly‐Mee Yu, et al.. (2023). Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND) in primary care: A protocol for a cluster randomised trial. Contemporary Clinical Trials. 129. 107199–107199. 1 indexed citations

Colosimo, Santo, Garry D. Tan, Maria Letizia Petroni, Giulio Marchesini, & Jeremy Tomlinson. (2022). Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent. Nutrition Metabolism and Cardiovascular Diseases. 33(3). 640–648. 17 indexed citations

Robinson, Danielle E, Ian Douglas, Garry D. Tan, et al.. (2021). Bariatric surgery increases the rate of major fracture: self-controlled case series study in UK Clinical Practice Research Datalink. Journal of Bone and Mineral Research. 36(11). 2153–2161. 7 indexed citations

10.

Ruan, Yue, et al.. (2020). Inpatient hypoglycaemia: understanding who is at risk. Diabetologia. 63(7). 1299–1304. 10 indexed citations

11.

Morris, Elizabeth, Paul Aveyard, Pamela Dyson, et al.. (2019). Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND): protocol for a randomised feasibility trial. BMJ Open. 9(1). e026460–e026460. 10 indexed citations

12.

Kozłowska, Olga, Alistair Lumb, Garry D. Tan, & Rustam Rea. (2018). Barriers and facilitators to integrating primary and specialist healthcare in the United Kingdom: a narrative literature review. Future Healthcare Journal. 5(1). 64–80. 63 indexed citations

13.

Jadoon, Khalid, Garry D. Tan, & Saoirse E. O’Sullivan. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2(12). 94 indexed citations

14.

Tan, Garry D., et al.. (2011). The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans. Lipids in Health and Disease. 10(1). 129–129. 27 indexed citations

15.

Karastergiou, Kalypso, Nicola Ogston, Rahul Bhome, et al.. (2009). RANTES release by human adipose tissue in vivo and evidence for depot-specific differences. American Journal of Physiology-Endocrinology and Metabolism. 296(6). E1262–E1268. 58 indexed citations

16.

Pérez‐Matute, Patricia, Matthew Neville, Garry D. Tan, Keith N. Frayn, & Fredrik Karpe. (2009). Transcriptional Control of Human Adipose Tissue Blood Flow. Obesity. 17(4). 681–688. 29 indexed citations

17.

Tahiri, Youssef, Fredrik Karpe, Garry D. Tan, & Katherine Cianflone. (2007). Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutrition & Metabolism. 4(1). 11–11. 17 indexed citations

18.

Evans, Kevin, Graham C. Burdge, Stephen A. Wootton, et al.. (2007). Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia. Atherosclerosis. 197(1). 164–170. 17 indexed citations

19.

Wake, Deborah J., Roland H. Stimson, Garry D. Tan, et al.. (2007). Effects of Peroxisome Proliferator-Activated Receptor-α and -γ Agonists on 11β-Hydroxysteroid Dehydrogenase Type 1 in Subcutaneous Adipose Tissue in Men. The Journal of Clinical Endocrinology & Metabolism. 92(5). 1848–1856. 32 indexed citations

20.

Tan, Garry D., Gijs H. Goossens, Sandy M. Humphreys, Hubert Vidal, & Fredrik Karpe. (2004). Upper and Lower Body Adipose Tissue Function: A Direct Comparison of Fat Mobilization in Humans. Obesity Research. 12(1). 114–118. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact